Clinical Trial Detail

NCT ID NCT01953588
Title Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements yes
Sponsors Alliance for Clinical Trials in Oncology
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Fulvestrant

Age Groups: adult

Additional content available in CKB BOOST